Company intelligence / Profile preview

TMC Pharma Services

Hartley Wintney, Hampshire, United Kingdomtmcpharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

TMC Pharma Services provides end-to-end drug development services from preclinical through post-marketing phases, specializing in rare/orphan diseases and advanced therapies. It partners with small-to-medium biotech/biopharma companies to accelerate the development of innovative treatments, particularly where patient populations are small or neglected. No proprietary clinical results as it operates as a CRO.

Therapeutic areas: OncologyRare Diseases
Modalities: Small moleculeBiologicCell therapy (including stem cell and other cell-based therapies)Advanced therapy investigational medicinal products (ATIMPs)Immuno-oncology agents
Industry: Contract Research Organization

Beyond the preview

Go deeper on TMC Pharma Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMC Pharma Services.

Explore the full profile